ArticleAnnals of translational medicine2021
Mass SARS-CoV-2 molecular and serological screening of medical staff and patients in Hangzhou, China: no evidence of RNA detection, low seroprevalence, and limited exposure risk in the hospital setting.
Jun Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.